ALDH1A2 and amyotrophic lateral sclerosis: Reductions in Raldh2 expression and RA signaling have been found in postmortem samples of patients with human amyotrophic lateral sclerosis (ALS) and Alzheimer's disease [100], [101], both exhibiting neurodegenerative phenotypes.